Reporte zur Charge EN6402

Symptomtext

extreme pain on injection; itchiness; redness; loss of motion in are instantly; extreme shortness of breath,; coughing; swelling; This is a spontaneous report from a contactable consumer (patient). A 62-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number EN6402, Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 17Mar2021 10:30 as dose 1, single for COVID-19 immunization (62 year when vaccinated). Medical history included drug hypersensitivity (Penicillin allergy) from an unknown date and unknown if ongoing, sensitive skin from an unknown date and unknown if ongoing, rubber sensitivity from an unknown date, allergy to animal from an unknown date. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, from an unknown start date. Patient did not receive vaccine in four weeks. On 17Mar2021 10:30, the patient experienced extreme pain on injection, itchiness, redness, swelling, loss of motion in are instantly. Over first 4 weeks extreme shortness of breath, coughing now. As of today 21Jul2021 - still have limited motion in are, breathing ok, but still sporadic coughing throughout the day. patinet went to an allergist/immunologist Dr., and orthopedic and rehab specialists. Nothing helping so far.The patient was treated for the events with Diclofenac sodium 75mg, manual physical therapy. Patient did not have covid prior vaccination. Patient was tested covid-19 post vaccination. The patient underwent Sars-CoV-2 test (PCR test) on 15Apr2021, and results were negative. The outcome of the events was reported as not recovering at the time of report.